| Industry | 批发和零售业 | ||||||||||||||||||||||||
| Company Introduction | 青岛百洋医药股份有限公司（简称“百洋医药”，股票代码：301015）成立于2005年，是A股领先的健康品牌商业化平台，核心业务聚焦全球优质医药健康产品的品牌运营打造，切实以科技创新优化医疗场景。 百洋医药凭借品类洞察及品牌打造、数字化营销和生态型组织协同核心能力，搭建“品牌高速公路”，为上游工业企业提供全渠道商业化解决方案，提升运营效率，促进行业规范化发展。经过十多年的积累，百洋医药已形成强大的营销网络，合作大中型医院14,000余家、药店近400,000家，孵化出多个品类领导品牌，产品矩阵覆盖OTC及大健康、OTX等处方药、肿瘤等重症药以及高端医疗器械四大品类，与上百家上游企业形成稳定合作关系。 | ||||||||||||||||||||||||
| Main Business | 为医药产品生产企业提供营销综合服务 | ||||||||||||||||||||||||
| Legal Representative | 付钢 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 王国强 | ||||||||||||||||||||||||
| Solicitors | 北京市天元律师事务所 | ||||||||||||||||||||||||
| Auditors | 立信会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0532-66756688 | ||||||||||||||||||||||||
| Fax No | 0532-67773768 | ||||||||||||||||||||||||
| Website | www.baheal.cn | ||||||||||||||||||||||||
| byyy@baheal.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 30/06/2021 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 1.250 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.762 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 4.887 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 14.029B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |